Malik; Ibrahim John
Patent Applications and Registrations
Patent applications and USPTO patent grants for Malik; Ibrahim John.The latest application filed is for "agents, uses and methods for treatment".
- Malik; Ibrahim John - Valby DK
| Patent | Date |
|---|---|
| Agents, uses and methods for the treatment of synucleinopathy Grant 11,421,024 - Kallunki , et al. August 23, 2 | 2022-08-23 |
| Agents, Uses And Methods For Treatment App 20210292414 - Biilmann Ronn; Lars Christian ; et al. | 2021-09-23 |
| Agent, Uses And Methods For Treatment App 20210269524 - Biilmann Ronn; Lars Christian ; et al. | 2021-09-02 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20210147522 - KALLUNKI; Pekka ; et al. | 2021-05-20 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20210061892 - KALLUNKI; Pekka ; et al. | 2021-03-04 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20210054057 - KALLUNKI; Pekka ; et al. | 2021-02-25 |
| Agents, uses and methods for treatment Grant 10,894,833 - Biilmann Ronn , et al. January 19, 2 | 2021-01-19 |
| Agent, uses and methods for treatment Grant 10,889,650 - Biilmann Ronn , et al. January 12, 2 | 2021-01-12 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 10,800,836 - Kallunki , et al. October 13, 2 | 2020-10-13 |
| Assay, Method And Treatment Of Alpha-synucleinopathies App 20200309796 - Malik; Ibrahim John ; et al. | 2020-10-01 |
| Agent, Uses And Methods For Treatment App 20200190188 - Biilmann Ronn; Lars Christian ; et al. | 2020-06-18 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 10,647,764 - Kallunki , et al. | 2020-05-12 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 10,647,763 - Kallunki , et al. | 2020-05-12 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 10,640,554 - Kallunki , et al. | 2020-05-05 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20190382473 - KALLUNKI; Pekka ; et al. | 2019-12-19 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20190367595 - Kallunki; Pekka ; et al. | 2019-12-05 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20190367594 - KALLUNKI; Pekka ; et al. | 2019-12-05 |
| Agent, uses and methods for treatment Grant 10,479,835 - Biilmann Ronn , et al. Nov | 2019-11-19 |
| Anti-sortilin antibodies, uses and methods for treatment Grant 10,428,147 - Biilmann Ronn , et al. October 1, 2 | 2019-10-01 |
| Antibodies for the treatment of synucleinopathy Grant 10,364,285 - Kallunki , et al. | 2019-07-30 |
| Antibodies for the treatment of synucleinopathy Grant 10,358,484 - Kallunki , et al. July 23, 2 | 2019-07-23 |
| Antibodies for the treatment of synucleinopathy Grant 10,358,483 - Kallunki , et al. July 23, 2 | 2019-07-23 |
| Antibodies for the treatment of synucleinopathy Grant 10,358,482 - Kallunki , et al. | 2019-07-23 |
| Agents, Uses And Methods For Treatment App 20190023788 - Ronn; Lars Christian Biilmann ; et al. | 2019-01-24 |
| Agent, Uses And Methods For Treatment App 20180305455 - Biilmann Ronn; Lars Christian ; et al. | 2018-10-25 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20180179271 - Kallunki; Pekka ; et al. | 2018-06-28 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20180179270 - Kallunki; Pekka ; et al. | 2018-06-28 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20180127491 - Kallunki; Pekka ; et al. | 2018-05-10 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20180127492 - Kallunki; Pekka ; et al. | 2018-05-10 |
| Agents, Uses and Methods for Treatment App 20170267761 - Biilmann Ronn; Lars Christian ; et al. | 2017-09-21 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20170015739 - Kallunki; Pekka ; et al. | 2017-01-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 